Financial Ratios

MIDAS PHARMASEC LTD.

NSE : NABSE : 530257ISIN CODE : INE113D01025Industry : TradingHouse : Private
BSE28.550 (0 %)
PREV CLOSE ( ) 28.55
OPEN PRICE ( ) 26.65
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 19878
TODAY'S LOW / HIGH ( )26.65 29.45
52 WK LOW / HIGH ( ) 26.6529.45
NSE
This Company is not listed in NSE
Select year
ParticularsMar2010Mar2009Mar2008Mar2007Mar2006
Operational & Financial Ratios
   Earnings Per Share (Rs)0.18-1.14-1.60-2.59-0.07
   CEPS(Rs)0.18-1.14-1.60-2.59-0.07
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)8.918.729.355.458.02
   Tax Rate(%)15.38-0.030.000.000.00
Margin Ratios
   Core EBITDA Margin(%)-41.32-920.50-294.67-345.33-16.73
   EBIT Margin(%)84.95-912.11-295.32-341.90-10.94
   Pre Tax Margin(%)84.95-912.19-295.48-341.97-10.96
   PAT Margin (%)71.89-912.43-295.48-341.97-10.96
   Cash Profit Margin (%)71.89-912.10-294.83-341.73-10.65
Performance Ratios
   ROA(%)1.97-21.71-14.76-36.70-0.85
   ROE(%)2.00-22.23-15.79-38.55-0.89
   ROCE(%)2.36-22.23-15.78-38.54-0.89
   Asset Turnover(x)0.030.020.050.110.08
   Sales/Fixed Asset(x)9.7626.4620.42
   Working Capital/Sales(x)0.030.010.060.140.08
Efficiency Ratios
   Fixed Capital/Sales(x)0.000.000.100.040.05
   Receivable days0.000.003631.351625.122247.46
   Inventory Days0.00988.422015.24581.44437.09
   Payable days8.6617.0112.48
Valuation Parameters
   PER(x)88.920.000.000.000.00
   PCE(x)88.91-10.49-5.06-3.28-32.32
   Price/Book(x)1.761.380.861.560.28
   Yield(%)0.000.000.000.000.00
   EV/Net Sales(x)36.7352.1214.7911.073.32
   EV/Core EBITDA(x)43.24-5.72-5.02-3.24-31.21
   EV/EBIT(x)43.24-5.71-5.01-3.24-30.35
   EV/CE(x)0.990.740.791.460.26
   M Cap / Sales63.9195.7014.9311.203.44
Growth Ratio
   Net Sales Growth(%)95.2737.88-64.3215.79703.48
   Core EBITDA Growth(%)118.19-326.6369.23-3617.2540.93
   EBIT Growth(%)118.19-325.8569.18-3517.0540.87
   PAT Growth(%)115.38-325.7769.17-3513.9041.05
   EPS Growth(%)115.3828.4738.35-3507.3941.05
Financial Stability Ratios
   Total Debt/Equity(x)0.000.000.000.000.00
   Current Ratio(x)266.871266.7134.89179.94131.84
   Quick Ratio(x)266.871231.9125.35124.52119.77
   Interest Cover(x)0.00-1838.35-4408.30-909.24
   Total Debt/Mcap(x)0.000.000.000.000.00

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.